Last 5 Days Trading Activity
|Date||Open Price||Close Price||High||Low||Volume|
Last 5 Days Short Activity
|Date||Short Volume||Total Volume||Short Percentage||Short Indicator|
* Short Mode
About Interactive Health Network (OTC: IGRW)
The Company specializes in advances in Supplements for Health, and Anti Aging with a special interest in Preventative Medicine. The Company was formed to distribute nutraceuticals formulas developed over thirty years of research by Dr. Kevin Buckman. Dr. Buckman has created more than a dozen fucoidan based formulas which are intended to address the needs of individuals suffering from DDS Degenerative Disease Syndrome , which includes such maladies as gastrointestinal disorders, auto immune diseases, asthma, Alzeimer s, dementia, diabetes, arthritis, cancer, and heart disease. lt br / gt lt br / gt The Company is focused on delivering nutraceutical formulas that can help diabetes and heart disease, along with new diagnostics for early detection of a predisposition to these disease states. Recognition of diabetes and vascular cardiac disease is a very important part of this program since over one half of men and women have significant cardiovascular disease and millions of Americans have Diabetes and don t know it. lt br / gt lt br / gt The growing concerns of oxidative stress have been shown to be an etiology of these diseases. There is also growing evidence of the benefits from the correct anti oxidant in a bio available and effective delivery system. Handling of oxidative stress of the billion cells of each of us is vital for quality of life and longevity. Peak performance and feeling of vitality is another important goal of The Company. lt br / gt lt br / gt Our mission is to provide medically proven modalities for Diabetes and assist lowering the costs of most expensive medical disorders in the United States and Worldwide. Diabetes and Heart Disease is increasing in frequency throughout the world at a rapid rate, they are related as inflammatory diseases and the most costly problem and biggest killers in the US. Current allopathic therapy is severely lacking in ability to provide sick care and preventive medical practices. lt br / gt lt br / gt Today the most costly medical problems we have are due to diabetes, heart disease, and cancer. Delivering products that provide better education for our customers that utilize scientifically based testing is the most important service we can offer. The proper focus for Chronic Diseases such as Diabetes and Heart Disease is centered on the proper metabolic pathways. The goal for Diabetes is not just control of the blood sugar. The goal for cardiac disease is not just good cholesterol levels. Both Diabetes and Heart Disease require more control over cellular and metabolic pathways that are responsible for the health of every person suffering from these diseases. All of our products have been designed to help a variety of people by providing them a feeling of better wellness.
- Fred Schiemann / Treasurer, Secretary
- Cesar D. Vazquez, III / Acting CEO, Acting President
- Fred Schiemann / Chairman
Current Share Structure
- Market Cap: $318,154 - 03/16/2018
- Authorized: 5,500,000,000 - 06/30/2015
- Issue and Outstanding: 3,181,539,520 - 08/20/2015
- Float: 1,525,942,120 - 08/20/2015
Daily Technical Chart for (OTC: IGRW)
Stay tuned for daily updates and more on (OTC: IGRW)
More to come on (OTC: IGRW)
Do your DD and if you choose, be ready to go!
The Research: All source information contained in this email is from the public sources mentioned below.
Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in IGRW is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of IGRW and does not buy, sell, or trade any shares of IGRW. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/